These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23512783)

  • 1. Letter by Ellims et al regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Ellims AH; Iles LM; Taylor AJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e1. PubMed ID: 23512783
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e2. PubMed ID: 23512784
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
    Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
    Circ Cardiovasc Imaging; 2012 Nov; 5(6):726-33. PubMed ID: 23071146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Taylor et al regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study".
    Taylor RJ; Umar F; Leyva F
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):e78. PubMed ID: 24254488
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Alter regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study".
    Alter P
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):e77. PubMed ID: 24254487
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of magnetic resonance myocardial delayed enhancement.
    Zhang ZH; Miao Q; Lin SB; Zhang SY; Li DJ; Chen LB; Zhang H; Wang YN; Zhou L; Kong LY; Feng F; You H; Sun HY; Zhao WM; Zhang LR; Jin ZY
    Chin Med Sci J; 2006 Dec; 21(4):245-51. PubMed ID: 17249200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study".
    Masci PG; Schuurman R; Barison A; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):e79. PubMed ID: 24254489
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
    Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
    Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy?
    Kramer CM; Chandrashekhar Y; Narula J
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):532-4. PubMed ID: 23579019
    [No Abstract]   [Full Text] [Related]  

  • 12. Merging strain-echo measurements with late gadolinium enhancement at cardiac MRI: An upcoming chance for advanced functional assessment of fibrosis in hypertrophic cardiomyopathy?
    de Gregorio C; Di Bella G
    Int J Cardiol; 2016 Jan; 203():632-4. PubMed ID: 26590884
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathies (hypertrophy and failure): what can offer cardiac magnetic resonance imaging?
    Silvera S; Strach K; Bogaert J; Sommer T; Vignaux O
    Presse Med; 2011 Sep; 40(9 Pt 2):e425-36. PubMed ID: 21795013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.
    Amano Y; Takayama M; Kumita S
    J Magn Reson Imaging; 2009 Oct; 30(4):778-84. PubMed ID: 19787718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T.
    Costello BT; Springer F; Hare JL; Gerche A; Iles L; Ellims AH; Schmitt B; Taylor AJ
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1551-1560. PubMed ID: 28589482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: The heart of the matter by looking into the matter of the heart.
    Peña-Peña ML; Gonzalvez-Garcia A; Navarro-Herrero S; Lucena-Romero J; Sanchez-Gomez A; Gonzalez-Campora R; Serrano-Gotarredona MP; Lopez-Pardo F; Lopez-Haldon JE; Urbano-Moral JA
    Int J Cardiol; 2016 Jan; 203():573-4. PubMed ID: 26569366
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
    Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
    Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.
    Görmeli CA; Özdemir ZM; Kahraman AS; Yağmur J; Özdemir R; Çolak C
    Radiol Med; 2017 Feb; 122(2):106-112. PubMed ID: 27785679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.